ASHP Guidelines on Preventing Diversion of Controlled Substances
2022 · American Journal of Health-System Pharmacy · 25 citations
https://doi.org/10.1093/ajhp/zxac246
A
Amanda Hays
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
643
Citations
12
h-index
14
i10-index
Amanda Hays is an academic researcher. The author has contributed to research in topics: Biosimilars and Bioanalytical Methods & Monoclonal and Polyclonal Antibodies Research & CAR-T cell therapy research. The author has an h-index of 12, co-authored 38 publications.
ORCID: 0000-0002-3429-4727Papers by this author
worksNeutralizing Antibody Validation Testing and Reporting Harmonization
2023 · The AAPS Journal · 24 citations
https://doi.org/10.1208/s12248-023-00830-5
Is Incurred Sample Reanalysis (ISR) Applicable in Biomarker Assays?
2022 · The AAPS Journal · 5 citations
https://doi.org/10.1208/s12248-022-00708-y
Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays
2023 · Pharmaceutical Research · 4 citations
https://doi.org/10.1007/s11095-023-03625-7
Implementation of flow cytometry testing on rare matrix samples: Special considerations and best practices when the sample is unique or difficult to obtain
2024 · Cytometry Part B Clinical Cytometry · 4 citations
https://doi.org/10.1002/cyto.b.22198
Best Practices and Recommendations for Non-Liquid Matrices Bioanalysis
2025 · The AAPS Journal · 3 citations
https://doi.org/10.1208/s12248-025-01033-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat